Aspen revenue up by 14%

2008-02-27 00:00

JSE-listed Aspen, Africa’s largest pharmaceutical manufacturer, this week recorded positive results for the period ended December 2007.

The consumer division increased revenue by three percent and the division in SA remains vulnerable to the retail cycle. The downturn in the cycle was compounded by the discontinuation of a range of laxatives due to the banning of phenolphthalein. publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Inside News24

Traffic Alerts
There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire network.